Gene editing at CRISPR speed View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-04-08

ABSTRACT

Ease of use, economy and speed of targeting DNA has propelled the CRISPR-Cas system into the spotlight. Now, despite numerous gaps in our knowledge, commercial entities are looking for a piece of the action. Monya Baker reports.

PAGES

309-312

Journal

TITLE

Nature Biotechnology

ISSUE

4

VOLUME

32

Related Patents

  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Compositions And Methods For Treating Cep290-Associated Disease
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Optimized Crispr-Cas Double Nickase Systems, Methods And Compositions For Sequence Manipulation
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Rna-Guided Human Genome Engineering
  • Targeted Modification Of Rat Genome
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Delivery, Engineering And Optimization Of Tandem Guide Systems, Methods And Compositions For Sequence Manipulation
  • Compositions And Methods For Treating Cep290-Associated Disease
  • Crispr-Cas Systems And Methods For Altering Expression Of Gene Products, Structural Information And Inducible Modular Cas Enzymes
  • Protected Guide Rnas (Pgrnas)
  • Crispr/Cas-Related Methods And Compositions For Treating Usher Syndrome And Retinitis Pigmentosa
  • Methods And Compositions For The Targeted Modification Of A Mouse Genome
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Functional Genomics Using Crispr-Cas Systems, Compositions, Methods, Screens And Applications Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr Enzyme Mutations Reducing Off-Target Effects
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Cas Systems And Methods For Altering Expression Of Gene Products
  • Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas
  • Crispr-Cas Systems And Methods For Altering Expression Of Gene Products, Structural Information And Inducible Modular Cas Enzymes
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Rna-Guided Human Genome Engineering
  • Rna-Guided Human Genome Engineering
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Cas Systems, Crystal Structure And Uses Thereof
  • Crispr/Cas-Related Methods And Compositions For Treating Leber's Congenital Amaurosis 10 (Lca10)
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation
  • Crispr-Cas Systems And Methods For Altering Expression Of Gene Products
  • Functional Genomics Using Crispr-Cas Systems, Compositions, Methods, Screens And Applications Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For The Targeted Modification Of A Mouse Embryonic Stem Cell Genome
  • Methods For Cleaving A Target Dna Using A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components
  • Compositions And Methods Of Use Of Crispr-Cas Systems In Nucleotide Repeat Disorders
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Escorted And Functionalized Guides For Crispr-Cas Systems
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Rna-Guided Human Genome Engineering
  • Escorted And Functionalized Guides For Crispr-Cas Systems
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Rna-Guided Human Genome Engineering
  • Crispr/Cas-Related Methods And Compositions For Treating Sickle Cell Disease
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr/Cas-Related Methods And Compositions For Treating Leber's Congenital Amaurosis 10 (Lca10)
  • Rna-Guided Human Genome Engineering
  • Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation
  • Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Evaluation Of Cas9 Molecule/Guide Rna Molecule Complexes
  • Crispr/Cas-Related Methods And Compositions For Treating Leber's Congenital Amaurosis 10 (Lca10)
  • Targeted Modification Of Rat Genome
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr-Based Genome Modification And Regulation
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Genome Editing
  • Methods, Models, Systems, And Apparatus For Identifying Target Sequences For Cas Enzymes Or Crispr-Cas Systems For Target Sequences And Conveying Results Thereof
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For The Targeted Modification Of A Genome
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy
  • Methods And Compositions Or Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Systems, Methods And Compositions For Sequence Manipulation With Optimized Functional Crispr-Cas Systems
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Crispr Enzyme Mutations Reducing Off-Target Effects
  • Systems, Methods And Compositions For Sequence Manipulation With Optimized Functional Crispr-Cas Systems
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Methods And Compositions Or Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nbt.2863

    DOI

    http://dx.doi.org/10.1038/nbt.2863

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1001687622

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/24714470


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "citation": [
          {
            "id": "sg:pub.10.1038/nbt.2808", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048637524", 
              "https://doi.org/10.1038/nbt.2808"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2800", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041802825", 
              "https://doi.org/10.1038/nbt.2800"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.2600", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024354143", 
              "https://doi.org/10.1038/nmeth.2600"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2623", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009511624", 
              "https://doi.org/10.1038/nbt.2623"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2842", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038520013", 
              "https://doi.org/10.1038/nbt.2842"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2647", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012543463", 
              "https://doi.org/10.1038/nbt.2647"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2675", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041659759", 
              "https://doi.org/10.1038/nbt.2675"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2673", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007302590", 
              "https://doi.org/10.1038/nbt.2673"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.2598", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049500416", 
              "https://doi.org/10.1038/nmeth.2598"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2507", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041881936", 
              "https://doi.org/10.1038/nbt.2507"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2501", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024988605", 
              "https://doi.org/10.1038/nbt.2501"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature09886", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030591890", 
              "https://doi.org/10.1038/nature09886"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2014-04-08", 
        "datePublishedReg": "2014-04-08", 
        "description": "Ease of use, economy and speed of targeting DNA has propelled the CRISPR-Cas system into the spotlight. Now, despite numerous gaps in our knowledge, commercial entities are looking for a piece of the action. Monya Baker reports.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nbt.2863", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1115214", 
            "issn": [
              "1087-0156", 
              "1546-1696"
            ], 
            "name": "Nature Biotechnology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "32"
          }
        ], 
        "keywords": [
          "numerous gaps", 
          "ease of use", 
          "entities", 
          "action", 
          "gene editing", 
          "use", 
          "DNA", 
          "CRISPR-Cas systems", 
          "knowledge", 
          "ease", 
          "spotlight", 
          "system", 
          "Baker", 
          "gap", 
          "commercial entities", 
          "editing", 
          "pieces", 
          "speed", 
          "economy"
        ], 
        "name": "Gene editing at CRISPR speed", 
        "pagination": "309-312", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1001687622"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nbt.2863"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "24714470"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nbt.2863", 
          "https://app.dimensions.ai/details/publication/pub.1001687622"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:58", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_640.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nbt.2863"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nbt.2863'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nbt.2863'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nbt.2863'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nbt.2863'


     

    This table displays all metadata directly associated to this object as RDF triples.

    109 TRIPLES      19 PREDICATES      53 URIs      35 LITERALS      6 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nbt.2863 schema:citation sg:pub.10.1038/nature09886
    2 sg:pub.10.1038/nbt.2501
    3 sg:pub.10.1038/nbt.2507
    4 sg:pub.10.1038/nbt.2623
    5 sg:pub.10.1038/nbt.2647
    6 sg:pub.10.1038/nbt.2673
    7 sg:pub.10.1038/nbt.2675
    8 sg:pub.10.1038/nbt.2800
    9 sg:pub.10.1038/nbt.2808
    10 sg:pub.10.1038/nbt.2842
    11 sg:pub.10.1038/nmeth.2598
    12 sg:pub.10.1038/nmeth.2600
    13 schema:datePublished 2014-04-08
    14 schema:datePublishedReg 2014-04-08
    15 schema:description Ease of use, economy and speed of targeting DNA has propelled the CRISPR-Cas system into the spotlight. Now, despite numerous gaps in our knowledge, commercial entities are looking for a piece of the action. Monya Baker reports.
    16 schema:genre article
    17 schema:isAccessibleForFree false
    18 schema:isPartOf N463df0bff3fa4b519eda2493b2806197
    19 N9f665f9156dd46b7bda49747e99e6012
    20 sg:journal.1115214
    21 schema:keywords Baker
    22 CRISPR-Cas systems
    23 DNA
    24 action
    25 commercial entities
    26 ease
    27 ease of use
    28 economy
    29 editing
    30 entities
    31 gap
    32 gene editing
    33 knowledge
    34 numerous gaps
    35 pieces
    36 speed
    37 spotlight
    38 system
    39 use
    40 schema:name Gene editing at CRISPR speed
    41 schema:pagination 309-312
    42 schema:productId N0dd8c95d3f944194883cf6d1df6188ba
    43 Nafb3f78373b54f94b6c7c4d9aa28dac8
    44 Ne95c6babfb1c4b6a930381d215af97fd
    45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001687622
    46 https://doi.org/10.1038/nbt.2863
    47 schema:sdDatePublished 2022-11-24T20:58
    48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    49 schema:sdPublisher N8211106964444c9c83310495d7504842
    50 schema:url https://doi.org/10.1038/nbt.2863
    51 sgo:license sg:explorer/license/
    52 sgo:sdDataset articles
    53 rdf:type schema:ScholarlyArticle
    54 N0dd8c95d3f944194883cf6d1df6188ba schema:name pubmed_id
    55 schema:value 24714470
    56 rdf:type schema:PropertyValue
    57 N463df0bff3fa4b519eda2493b2806197 schema:issueNumber 4
    58 rdf:type schema:PublicationIssue
    59 N8211106964444c9c83310495d7504842 schema:name Springer Nature - SN SciGraph project
    60 rdf:type schema:Organization
    61 N9f665f9156dd46b7bda49747e99e6012 schema:volumeNumber 32
    62 rdf:type schema:PublicationVolume
    63 Nafb3f78373b54f94b6c7c4d9aa28dac8 schema:name doi
    64 schema:value 10.1038/nbt.2863
    65 rdf:type schema:PropertyValue
    66 Ne95c6babfb1c4b6a930381d215af97fd schema:name dimensions_id
    67 schema:value pub.1001687622
    68 rdf:type schema:PropertyValue
    69 sg:journal.1115214 schema:issn 1087-0156
    70 1546-1696
    71 schema:name Nature Biotechnology
    72 schema:publisher Springer Nature
    73 rdf:type schema:Periodical
    74 sg:pub.10.1038/nature09886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030591890
    75 https://doi.org/10.1038/nature09886
    76 rdf:type schema:CreativeWork
    77 sg:pub.10.1038/nbt.2501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024988605
    78 https://doi.org/10.1038/nbt.2501
    79 rdf:type schema:CreativeWork
    80 sg:pub.10.1038/nbt.2507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041881936
    81 https://doi.org/10.1038/nbt.2507
    82 rdf:type schema:CreativeWork
    83 sg:pub.10.1038/nbt.2623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009511624
    84 https://doi.org/10.1038/nbt.2623
    85 rdf:type schema:CreativeWork
    86 sg:pub.10.1038/nbt.2647 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012543463
    87 https://doi.org/10.1038/nbt.2647
    88 rdf:type schema:CreativeWork
    89 sg:pub.10.1038/nbt.2673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007302590
    90 https://doi.org/10.1038/nbt.2673
    91 rdf:type schema:CreativeWork
    92 sg:pub.10.1038/nbt.2675 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041659759
    93 https://doi.org/10.1038/nbt.2675
    94 rdf:type schema:CreativeWork
    95 sg:pub.10.1038/nbt.2800 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041802825
    96 https://doi.org/10.1038/nbt.2800
    97 rdf:type schema:CreativeWork
    98 sg:pub.10.1038/nbt.2808 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048637524
    99 https://doi.org/10.1038/nbt.2808
    100 rdf:type schema:CreativeWork
    101 sg:pub.10.1038/nbt.2842 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038520013
    102 https://doi.org/10.1038/nbt.2842
    103 rdf:type schema:CreativeWork
    104 sg:pub.10.1038/nmeth.2598 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049500416
    105 https://doi.org/10.1038/nmeth.2598
    106 rdf:type schema:CreativeWork
    107 sg:pub.10.1038/nmeth.2600 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024354143
    108 https://doi.org/10.1038/nmeth.2600
    109 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...